Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalent

63.48
+0.0000
Volume:- -
Turnover:- -
Market Cap:11.52B
PE:-27.83
High:63.48
Open:63.48
Low:63.48
Close:63.48
Loading ...

Sanofi CFO Says Novo's Acquisition of Catalent Makes Sense for Them Because They Desperately Need Capacity, but No Further Comment as It Has No Implications for Sanofi

THOMSON REUTERS
·
25 Oct 2024

Sanofi CFO says won't be affected by Novo's Catalent deal

Reuters
·
25 Oct 2024

CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases

Zacks
·
24 Oct 2024

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

Benzinga
·
24 Oct 2024

Market Chatter: Catalent-Novo Holdings Deal Opposed by Roche CEO

MT Newswires
·
24 Oct 2024

Roche CEO says antitrust regulators should block Catalent sale to Novo Foundation

seekingalpha
·
23 Oct 2024

UPDATE 1-Roche comes out against clearing takeover of drug manufacturer Catalent

Reuters
·
23 Oct 2024

Roche CEO comes out against approving takeover of drug manufacturer Catalent

Reuters
·
23 Oct 2024

Roche Executive Graham: We Don’t See Anything That Is Slowing Down Momentum in Demand for Eye Drug Vabysmo, It Is Competing Exceptionally Well

THOMSON REUTERS
·
23 Oct 2024

Roche CEO When Asked About Catalent Takeover: Limiting Competition in This Way Is Not Ideal, Not a Problem for US but for Smaller Players and for the Wider Industry

THOMSON REUTERS
·
23 Oct 2024

Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year?

Zacks
·
22 Oct 2024

Catalent to Continue Operating as CDMO After Novo Holdings Buyout, CEO Says

MT Newswires Live
·
22 Oct 2024

Catalent CEO to remain in charge of contract drugmaker after Novo completes buyout

Reuters
·
21 Oct 2024

Catalent issues letter to customers regarding acquisition by Novo Holdings

TIPRANKS
·
21 Oct 2024

BRIEF-Catalent Issues Open Letter To Customers Regarding Pending Acquisition By Novo Holdings

Reuters
·
21 Oct 2024

Catalent Inc - Alessandro Maselli to Remain President and CEO Post-Close

THOMSON REUTERS
·
21 Oct 2024